Oramed Pharmaceuticals (ORMP) Tax Provisions (2016 - 2026)
Oramed Pharmaceuticals (ORMP) posted Tax Provisions of $11.1 million for Q1 2026, up 197.65% on a QoQ basis from -$11.4 million in Q4 2025, and up 1805.82% year-over-year from $584000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Tax Provisions (2016 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Tax Provisions history runs 6 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- Quarterly Tax Provisions rose 1805.82% year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 million (up 183.2% YoY) and the FY2025 annual result came in at $122000.0, down 96.17% from the prior year.
- Tax Provisions was $11.1 million for Q1 2026 at Oramed Pharmaceuticals, up from -$11.4 million in the prior quarter.
- Across five years, Tax Provisions topped out at $11.1 million in Q1 2026 and bottomed at -$11.4 million in Q4 2025.
- A 4-year average of $1.4 million and a median of $500000.0 in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2025 — Tax Provisions plunged 2839.9% — and 2026, when it jumped 1805.82%.
- Oramed Pharmaceuticals' Tax Provisions stood at -$200000.0 in 2022, then soared by 308.0% to $416000.0 in 2024, then plunged by 2839.9% to -$11.4 million in 2025, then surged by 197.65% to $11.1 million in 2026.
- Business Quant data shows ORMP's Tax Provisions at $11.1 million in Q1 2026, -$11.4 million in Q4 2025, and $11.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 11.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.13 Mn |
| Dec 31, 2025 | -11.40 Mn |
| Sep 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | -126,000.00 |
| Mar 31, 2025 | 584,000.00 |
| Dec 31, 2024 | 416,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Dec 31, 2022 | -200,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Aug 31, 2019 | -600,000.00 |
| Feb 28, 2019 | 300,000.00 |
| Nov 30, 2016 | 400,000.00 |